全文获取类型
收费全文 | 44篇 |
免费 | 2篇 |
专业分类
妇产科学 | 5篇 |
临床医学 | 8篇 |
内科学 | 9篇 |
神经病学 | 2篇 |
特种医学 | 5篇 |
外科学 | 1篇 |
综合类 | 5篇 |
预防医学 | 7篇 |
药学 | 4篇 |
出版年
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2016年 | 2篇 |
2015年 | 1篇 |
2014年 | 2篇 |
2013年 | 1篇 |
2010年 | 1篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1990年 | 5篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1959年 | 2篇 |
1958年 | 4篇 |
1957年 | 2篇 |
1956年 | 2篇 |
1955年 | 5篇 |
1954年 | 1篇 |
1945年 | 1篇 |
排序方式: 共有46条查询结果,搜索用时 31 毫秒
1.
2.
J. U. WEAVER J. M. P. HOLLY P. G. KOPELMAN K. NOONAN C. G. GIADOM N. WHITE S. VIRDEE J. A. H. WASS 《Clinical endocrinology》1990,33(3):415-422
Obesity may be characterized by abnormal sex steroid secretion and reduced sex hormone binding globulin (SHBG) which in turn is related to fat distribution and insulin secretion. Recent in-vitro and in-vivo evidence suggests that insulin is the common mechanism regulating the secretion of SHBG and insulin-like growth factor small binding protein (IGFBP-1). IGFBP-1 appears not only to be a carrier for insulin growth factors (IGFs) but also to play an active role in growth processes, independent of growth hormone secretion. We have examined the possible relationship between fasting insulin, SHBG, testosterone, IGF-1, IGFBP-1 and fat distribution in 25 extremely obese, menstruating women (mean weight 107 +/- 3 kg) with normal glucose tolerance. Fat distribution was assessed from measurements of the waist to hip ratio (W/H). The obese women showed an elevated fasting insulin (mean +/- SEM; 21 +/- 2 mumol/l), a normal IGF-1, but reduced IGFBP-1 (14.6 +/- 2 micrograms/l); in 15 women IGFBP-1 levels were undetectable by the present assay. In addition, SHBG levels were reduced in the obese women (24 +/- 2 nmol/l) but total testosterone values (1.9 +/- 0.1 nmol/l) were normal. The elevated fasting insulin levels were positively correlated with increasing upper segment obesity as expressed by a rising W/H ratio (P less than 0.01, r2 = 0.306) and inversely correlated with SHBG (P less than 0.01, r2 = 0.483). Similarly, reduced SHBG values showed an inverse correlation with increasing W/H ratio (P less than 0.001, r2 = 0.383). No correlation was found between IGFBP-1 and W/H ratio but a strong positive correlation was seen between IGFBP-1 and SHBG (P less than 0.001, r2 = 0.466). Furthermore, an equally significant inverse correlation was found between IGFBP-1 and insulin levels (P less than 0.001, r2 = 0.474).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
3.
J. M. P. HOLLY J. A. EDEN J. ALAGHBAND-ZADEH G. D. CARTER R. C. JEMMOTT S. CIANFARANI T. CHARD J. A. H. WASS 《Clinical endocrinology》1990,33(1):53-64
There is now considerable evidence that the insulin-like growth factors (IGFs) play an important role in the human ovary. It has also recently become apparent that the physiological activity of the IGFs is modulated by a number of specific binding proteins (IGFBPs). In order to understand the role of the IGFs in ovarian physiology, the presence and functions of these IGFBPs will need to be characterized. As an initial step towards this we have investigated the presence of the various binding proteins by Western ligand blotting and have measured the levels of one of them, IGFBP-1, in follicular fluid (FF) obtained from unstimulated dominant and cohort follicles in 19 normal women and in eight patients with polycystic and one with multicystic ovaries. In normal women, IGFBP-1 levels in dominant follicles were similar to matched serum levels but were significantly lower in cohort follicles. IGFBP-1 levels correlated with FF-volume (r = 0.58, P less than 0.001) and with paired serum levels (r = 0.63, P less than 0.001). In post-LH surge dominant follicles this relationship with serum levels no longer held and in three out of nine subjects FF levels were higher than in serum. Thus IGFBP-1 in normal human FF appears to be partly derived from the circulation but with additional local production in the larger developing dominant follicles. Western ligand blotting revealed five IGF-binding proteins in FF running parallel with those identified in serum, suggesting that the IGFBP species previously identified in serum may also be present in FF. The two bands in positions corresponding to the components of the large (150kDa) binding complex were, as in serum, the predominant forms and in most FF samples these were even more prominent than in the accompanying serum sample. This contrasts with previous studies in lymph which suggested that the 150kDa complex was largely retained in the circulation. All three small IGFBPs varied considerably between FF samples even within an individual; each IGFBP varied independently of the other IGFBPs. Our results demonstrate that at least four discrete IGFBPs are present in FF and suggest that each may be produced independently within the ovary. 相似文献
4.
Linking: A Mechanism of Intermittent Preexcitation in the Wolff-Parkinson-White Syndrome 总被引:1,自引:0,他引:1
HOLLY R. MIDDLEKAUFF WILLIAM G. STEVENSON THOMAS S. KLITZNER 《Pacing and clinical electrophysiology : PACE》1990,13(12):1629-1636
MIDDLEKAUFF, H.R., ET AL.: Linking: A Mechanism of Intermittent Preexcitation in the Wolff-Parkinson-White Syndrome. Intermittent preexcitation in the Wolff-Parkinson-White syndrome has been equated with a long accessory pathway refractory period and long R-R interval between preexcited beats in atrial fibrillation and therefore a low risk for sudden death. A case of Wolff-Parkinson-White syndrome in which preexcitation became intermittent following procainamide infusion, with only moderate prolongation of the accessory pathway refractory period but marked prolongation of the shortest preexcited R-R interval in atrial fibrillation, is described. Programmed ventricular and atrial stimulation demonstrated that intermittent preexcitation was caused by concealed conduction producing a linking phenomenon, facilitated by the antiarrhythmic drug. Linking due to concealed retrograde penetration of a propagated impulse into the accessory pathway may contribute to the disparity between accessory pathway refractory period and shortest preexcited R-R interval in atrial fibrillation in some patients and may be a confounding factor in the interpretation of noninvasive tests of accessory pathway conduction. 相似文献
5.
6.
HOLLY HAGAN DON C. DES JARLAIS DAVID PURCHASE SAMUEL R. FRIEDMAN TERRY REID THOMAS A. BELL 《Addiction (Abingdon, England)》1993,88(12):1691-1697
Although European and Australian studies of syringe exchange programs have reported safer injection among participants and no increase in drug use, the generalizability of these findings to the US is uncertain. We report on the operations and potential effectiveness of the longest-operating syringe exchange in the US and compare our results to studies of exchange programs outside the US. The sample of 204 study subjects reported no change in the frequency of injection, from 155 to 152 injections per month, and a decline in the frequency of unsafe injections, from 56 to 30 times per month, while participating in the program. In all studies, participants report reduction in unsafe injections, and no increase in illicit drug use. However, the comparison also suggests that a high proportion of Tacoma exchangers have higher initial rates of drug injection, unsafe injection and homelessness, all of which were associated with unsafe injection while using the exchange. These indicate a need for additional services but that the Tacoma program is no less effective than European and Australian programs. 相似文献
7.
8.
9.
Ventricular Arrhythmia Burden in Patients With Heart Failure and Cardiac Resynchronization Devices: The Importance of Renal Function 下载免费PDF全文
GIRISH GANESHA BABU M.D. M.R.C.P. MATTHEW WEBBER M.R.C.P. M.B.Ch.B. RUI PROVIDENCIA M.D. SANJEEV KUMAR M.D. M.R.C.P. Ph.D. AERAKONDAL GOPALAMURUGAN M.D. M.R.C.P. C.C.D.S. DOMINIC P. ROGERS M.A. M.D. M.R.C.P. HOLLY LOUISE DAW B.Sc. SYED AHSAN M.D. M.R.C.P. ANTHONY CHOW M.D. F.R.C.P. MARTIN LOWE Ph.D. F.R.C.P. EDWARD ROWLAND M.D. F.R.C.P. F.E.S.C. F.A.C.C. PIER LAMBIASE Ph.D. F.R.C.P. F.H.R.S. OLIVER R. SEGAL M.D. F.R.C.P. F.H.R.S. 《Journal of cardiovascular electrophysiology》2016,27(11):1328-1336
10.
J. M. P. HOLLY R. A. BIDDLECOMBE D. B. DUNGER J. A. EDGE S. A. AMIEL R. HOWELL T. CHARD L. H. REES J. A. H. WASS 《Clinical endocrinology》1988,29(6):667-675
Evidence is accumulating that a non-GH dependent insulin-like growth factor-binding protein (IGF-BP) is not only a carrier protein but also has an active role in the growth process. We have measured levels of this IGF-BP, using a specific RIA, over 12 or 24-h periods in 11 adolescents with diabetes mellitus and five normal adults. In each of the normal the IGF-BP was undetectable for most of the day but with a broad nocturnal peak observed, with levels up to 50 micrograms/l. The levels of IGF-BP were unrelated to the secretory pattern for GH but correlated inversely with the concentration of circulating insulin. In the diabetics a very similar pattern was observed, but with detectable levels throughout the day and much higher peak levels seen at night. Peak levels were up to 120 micrograms/l if a long-acting insulin preparation was administered in the evening but were 400-500 micrograms/l if the long-acting preparation was administered in the morning. The IGF-BP was strongly correlated with plasma glucose in this latter group. In a further group of diabetics overnight profiles were obtained on two separate nights, a normal night and a night with euglycaemia maintained with a glucose clamp technique. Euglycaemia failed to affect peak levels of the binding protein, although the shape of the nocturnal peak was altered consistent with the altered pattern of circulating free insulin. In this group a strong inverse correlation was obtained between the IGF-BP and free insulin levels.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献